Catyalyst Pharma (CPRX) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.47 --0%
Revenue Growth %: +6.2%
Financial Fact:
Net loss: -3.95M
Today's EPS Names:
CCEL, SLP, TMQ, More
Revenue Growth %: +6.2%
Financial Fact:
Net loss: -3.95M
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman lowers Mattel rating to Sell on macro and execution risks; shares dip
- Strategy to report Q2 2026 results on July 30
- UBS Reiterates Buy Rating on Comfort Systems USA (FIX) Amid Robust Demand Environment
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
